For most of a decade, Lance Armstrong was the greatest comeback story in sport: a Texan who survived metastatic testicular cancer in 1996 and then won the Tour de France seven straight times, from 1999 to 2005. On August 24, 2012, the United States Anti-Doping Agency stripped all of it. He declined to contest the charges in arbitration, and USADA imposed a lifetime ban and disqualified every result he had recorded since August 1, 1998. On October 22, 2012, cycling’s governing body, the UCI, accepted the sanction and formally erased the seven titles. The Tour chose not to award them to anyone else. The record book for 1999 through 2005 now reads blank, which is its own kind of verdict.
The case against him was not a failed drug test. It was, in USADA’s published account, “the most sophisticated, professionalized and successful doping program that sport has ever seen” — a team-wide system on the US Postal Service squad built around EPO, blood transfusions, testosterone, cortisone, and human growth hormone, with saline infusions and careful timing used to stay ahead of the testers. USADA laid it out in October 2012 in a roughly 200-page Reasoned Decision backed by more than a thousand pages of evidence and the sworn testimony of 26 witnesses, including 15 riders and 11 of Armstrong’s own former teammates.
For years Armstrong’s defense had been four words long — I never failed a test — and in the narrow, technical sense it was almost true, which was precisely the problem the evidence exposed. He had not been caught by a vial of urine. He had been caught by the people who had doped alongside him. The man who had sued his accusers for defamation, and won settlements doing it, confessed the whole thing to Oprah Winfrey on television in January 2013.
The fall was not only reputational. Sponsors left in a single day; he stepped down from the cancer foundation he had built; and in 2018 he paid the US government $5 million to settle a whistleblower fraud suit brought by the teammate who had started the unravelling. What follows is how the most tested athlete in cycling ran the sport’s most elaborate doping program in plain sight, and how it finally came apart from the inside.
The Festina affair began with a traffic stop and ended by nearly killing the Tour de France. On July 8, 1998, three days before that year’s race set off from Dublin, French customs officers stopped a Festina team car near the Belgian border and found it stocked like a pharmacy: hundreds of doses of erythropoietin (EPO), growth hormone, testosterone, amphetamines, and the syringes to deliver them. The driver was Willy Voet, a soigneur for the Festina cycling team, then one of the strongest in the world. On July 18, after team director Bruno Roussel acknowledged an organized doping system, Tour director Jean-Marie Leblanc expelled Festina from the race. The verdict on record is an expulsion — the whole team, removed mid-Tour.
The drugs in Voet’s car were not a personal stash. The investigation, built on documents seized from the team and the confessions of riders, established that Festina ran a coordinated, team-funded doping program, with riders contributing to a common kitty and the medical staff managing the supply. EPO, the red-cell-boosting hormone that had quietly transformed endurance cycling, was at its center. Eight of the team’s nine riders were later found to have synthetic EPO in their samples. This was not an athlete cheating in spite of his team; it was a team cheating on behalf of its athletes, with the books to prove it.
The scandal did not stop at one car or one team. As the Tour ground on, police raided other squads, found EPO in the TVM team’s vehicles, took riders into custody, and provoked the peloton into a sit-down strike in protest at the raids. Several teams abandoned the race. Marco Pantani won a Tour that had spent three weeks looking as though it might not finish at all, and which the French press openly wondered should be abandoned for good.
The legal reckoning, at a 2000 trial in Lille, produced suspended sentences and fines for the staff who had run the system — Voet, Roussel, and others — rather than the riders, most of whom escaped criminal punishment. But the affair’s largest consequence was structural. The spectacle of a sport unable to police itself pushed the International Olympic Committee to convene a conference that, in 1999, created the World Anti-Doping Agency. The team that got expelled left behind the body that would do the expelling everywhere else.
Alberto Contador, the Spanish climber who had already won three Tours de France and was the dominant stage racer of his generation, was stripped of his 2010 Tour de France title and his 2011 Giro d’Italia victory after the Court of Arbitration for Sport ruled, on February 6, 2012, that he had committed a doping offence. The substance was clenbuterol, found in a urine sample on the second rest day of the 2010 Tour. The amount was vanishingly small — fifty picograms per millilitre, a level so low that the case became less about whether the drug was there than about how it had got there. CAS handed him a two-year ban backdated to January 25, 2011, and erased everything he had won in between.
The defence was a steak. Contador’s team argued that a friend had brought beef across the border from Spain, and that the meat had been contaminated with clenbuterol — a drug given illegally to cattle in some countries to build lean muscle. It was not an absurd story; meat contamination is real enough that WADA has formally warned athletes about it in China and Mexico. But under strict liability, an athlete is responsible for what is in his body regardless of how it arrived, and the only way out is to prove the innocent route on the balance of probabilities. Contador could not.
The institutional path was as much the story as the chemistry. After the positive was announced in September 2010, the matter went to the Spanish cycling federation, the RFEC, which first proposed a one-year ban and then, in early 2011, cleared Contador entirely. The Union Cycliste Internationale and the World Anti-Doping Agency each appealed that acquittal to CAS — the court that sits above national federations precisely so that a home body cannot have the final word on its own star. CAS overturned the clearance, the rare and telling feature of the case: an athlete acquitted at home, convicted on appeal.
CAS, notably, did not endorse the steak. Investigators found no clenbuterol in the traced beef, and the panel judged meat contamination very unlikely; it also rejected the prosecution’s theory of a blood transfusion as unproven. Its actual finding was a third option: that the most probable source was a contaminated food supplement. The verdict on record, then, is a two-year ban and two vacated Grand Tours, resting not on proof of how the drug entered Contador’s body but on his failure to prove it had entered innocently.
Operación Puerto was the Spanish police investigation that, in May 2006, cracked open the blood-doping ring run by the Madrid sports doctor Eufemiano Fuentes — and produced a paradox that still defines it. The athletes who used the ring were banned; the doctor who ran it walked free. When the Guardia Civil raided Fuentes’s premises they found roughly two hundred coded bags of frozen blood and plasma, a refrigerated library of athletes’ own blood waiting to be reinfused at the competition moments that mattered. The sporting verdicts followed over several years; the criminal verdict against Fuentes was overturned on a legal technicality so tidy it has become the case’s epitaph.
The mechanism was autologous blood doping — the oldest trick in endurance sport, modernized into a service. An athlete’s blood would be withdrawn, stored, and reinfused later to raise the red-cell count and the oxygen-carrying capacity that cycling lives on, often alongside EPO. Because the reinfused blood was the athlete’s own, it left little for a standard test to catch; the evidence was not in the rider’s veins on test day but in Fuentes’s freezers, labelled with code names. “Puerto,” fittingly for a cycling scandal, is Spanish for a mountain pass — the operation was, in effect, Operation Mountain Pass. The code names became the case’s grim parlour game: bags marked “Jan” or numbered identifiers were matched by DNA to specific riders.
The sporting reckoning, when it came, was real. Jan Ullrich, the 1997 Tour de France champion, was banned for two years by the Court of Arbitration for Sport in February 2012, with his results from May 2005 to his 2007 retirement annulled — including his third place at the 2005 Tour. Ivan Basso, identified by the code name “Birillo” (the name of his dog), was suspended after admitting involvement and pulled from the 2006 Giro. Alejandro Valverde, linked by DNA to a bag, was banned for two years by CAS on a worldwide basis, backdated to January 2010. The ring’s clients paid in suspensions and erased palmarès.
Fuentes did not. A Madrid court convicted him in 2013 of a public-health offence — a one-year suspended sentence plus a four-year ban from sports medicine — and ordered the bags of blood destroyed. In June 2016 a higher Madrid court acquitted him outright, reasoning that a person’s own blood reinfused into that person is not a “substance” endangering public health under the statute, and noting the inconvenient truth that doping was not a crime in Spain when the ring operated. WADA and the UCI had to fight just to stop the evidence being incinerated. The doctor went free; the blood, very nearly, went into the furnace.